Löschung

Novacyt launches a new coronavirus screening test ... and is booming on the stock market. The molecular test of Primerdesign has the capacity to detect only the 2019 strain of the virus, indicates the company Novacyt, specialized in diagnostics. Shortly after this announcement, its price jumped on the Paris Stock Exchange this morning. "We believe that our test is the first European test to be launched and will be launched this weekend at the Medlab exhibition in the Middle East," said Graham Mullis, managing director of the company whose action earns more than 16% at 10 a.m., valuing the company at around 17 million euros.

BBC has reported 'China asked the European Union to facilitate the sending of medical supplies from member countries'

www.lse.co.uk/ShareChat.asp?ShareTicker=NCYT&share=Novacyt

mobile.twitter.com/MicrogenBioProd/status/1224248967476731905

live.euronext.com/en/product/equities/FR0010397232-ALXP

pdfhost.io/v/...g_Novacyt_SA_UK_Edition_3rd_February_2020.pdf